These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Clinical expeiences with special indications for proscillaridine A in elderly and cirrhotic patients]. Strobbia R; Beggiato O; Manzoni A G Gerontol; 1967 Jul; 15(7):827-64. PubMed ID: 5606219 [No Abstract] [Full Text] [Related]
24. [Rational prescription of cardiac stimulants]. Rietbrock N; Abshagen U; von Bergmann K; Kewitz H Dtsch Med J; 1972 Feb; 23(2):100-5. PubMed ID: 5017962 [No Abstract] [Full Text] [Related]
25. [Some mathematical remarks on the problem of standardization of cardiac glycosides]. Schneider B Arzneimittelforschung; 1967 Oct; 17(10):1242-3. PubMed ID: 5632868 [No Abstract] [Full Text] [Related]
26. [Olitoriside--a glycoside from the seeds of Corchorus olitorius L. (review of the literature)]. Samilova RD; Lagodich TA Vrach Delo; 1977 Jan; (1):27-31. PubMed ID: 847942 [No Abstract] [Full Text] [Related]
27. [Clinical evaluation of the effectiveness of treatment with cardiac glycosides]. Mukharliamov NM; Tsibekmakher TD Kardiologiia; 1975 Jul; 15(7):141-53. PubMed ID: 1206841 [No Abstract] [Full Text] [Related]
28. [Structure and effect of cardiac glycosides from the clinical viewpoint]. Sundermann A; Fiehring H Dtsch Gesundheitsw; 1967 May; 22(20):919-23. PubMed ID: 5600800 [No Abstract] [Full Text] [Related]
29. [Interactions between drugs used in cardiology]. Halawa B; Mazurek W Wiad Lek; 1980 Apr; 33(7):533-8. PubMed ID: 6994358 [No Abstract] [Full Text] [Related]
30. [Current aspects of drug therapy of chronic heart failure]. Ol'binskaia LI Kardiologiia; 1983 Jul; 23(7):5-11. PubMed ID: 6620812 [No Abstract] [Full Text] [Related]
31. [Therapeutic experiences with proscillaridin A in decompensated heart diseases]. Verga L; Forzani GF Minerva Med; 1967 Dec; 58(96):4318-22. PubMed ID: 6083293 [No Abstract] [Full Text] [Related]
32. [Effect of cardiac glycosides on the contractile function of the heart according to polycardiographic data]. Murashko VE; Shaĭkeevich KF; Otrokova EI Sov Med; 1970 Feb; 33(2):135-7. PubMed ID: 5457132 [No Abstract] [Full Text] [Related]
33. [Current problems of pharmacotherapy. VII. Aspects of an ambulatory glycoside therapy]. Herling M; Oehme P; Parsi RA Dtsch Gesundheitsw; 1969 Dec; 24(49):2305-9. PubMed ID: 5405889 [No Abstract] [Full Text] [Related]
34. [Preliminary clinical experences and therapeutic use of a new cardioactive glycoside (Stellarid)]. Messina D Minerva Med; 1967 Dec; 58(96):4289-96. PubMed ID: 6083291 [No Abstract] [Full Text] [Related]
35. [Proscillaridin A in some senile heart diseases. Preliminary clinico-therapeutic observations]. Guerricchio G; Basile F; Tantalo L Minerva Med; 1966 May; 57(43 Suppl):1982-90. PubMed ID: 5943256 [No Abstract] [Full Text] [Related]
36. [Treatment of hypoxic heart insufficiency in old age]. Köhler U Ther Ggw; 1967 Mar; 106(3):384-8. PubMed ID: 5594296 [No Abstract] [Full Text] [Related]
37. [The significance of phase analysis in the pharmacotherapeutic control of the effect of cardiac glycosides]. Belostochnaia NG Ter Arkh; 1967 Apr; 39(4):65-7. PubMed ID: 5610908 [No Abstract] [Full Text] [Related]
38. [Are cardiac glycosides recommended following an attack of encephalomalacia?]. Aschenbrenner R Dtsch Med Wochenschr; 1968 Jan; 93(1):48. PubMed ID: 5635032 [No Abstract] [Full Text] [Related]
40. [A contribution to the problem of dosage of cardiac glycosides after a change in glycoside preparation. Mathematical models of optimal dosage (author's transl)]. Kratochvíl L; Lustig M Basic Res Cardiol; 1974; 69(6):573-84. PubMed ID: 4451545 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]